News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ophthotech Corporation (OPHT) To Host R&D Day On March 7, 2014


3/4/2014 8:12:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ophthotech Corporation (Nasdaq:OPHT) today announced that the Company will host a live webcast in conjunction with its Research and Development (R&D) Day on Friday, March 7, 2014, beginning at 8:30 a.m. ET. A panel featuring leading retinal specialists will discuss the company’s expanded clinical programs for Fovista™ anti-PDGF therapy in combination with anti-VEGF drugs for wet AMD. In addition, an update on Zimura™, an inhibitor of complement factor C5 for the dry and wet forms of AMD, will also be provided.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES